The Cooper Companies, Inc. (NYSE:COO) Director Robert S. Weiss Sells 37,510 Shares of Stock

Posted by Defense World Staff on Mar 8th, 2023

The Cooper Companies, Inc. (NYSE:COO – Get Rating) Director Robert S. Weiss sold 37,510 shares of the firm’s stock in a transaction that occurred on Tuesday, March 7th. The shares were sold at an average price of $337.72, for a total value of $12,667,877.20. Following the transaction, the director now directly owns 70,000 shares of the company’s stock, valued at approximately $23,640,400. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Cooper Companies Stock Performance

COO stock opened at $336.34 on Wednesday. The company has a market cap of $16.62 billion, a P/E ratio of 44.55, a price-to-earnings-growth ratio of 2.52 and a beta of 0.89. The Cooper Companies, Inc. has a 1 year low of $244.21 and a 1 year high of $429.89. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.72 and a quick ratio of 1.00. The stock’s fifty day moving average price is $341.80 and its 200-day moving average price is $310.67.

Cooper Companies (NYSE:COO – Get Rating) last released its quarterly earnings results on Thursday, March 2nd. The medical device company reported $2.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.66 by $0.24. The firm had revenue of $858.50 million for the quarter, compared to the consensus estimate of $834.90 million. Cooper Companies had a return on equity of 8.39% and a net margin of 11.10%. The company’s revenue for the quarter was up 9.1% on a year-over-year basis. During the same period last year, the business posted $3.24 EPS. On average, equities analysts forecast that The Cooper Companies, Inc. will post 12.67 earnings per share for the current year.

Cooper Companies Dividend Announcement

The company also recently declared a Semi-Annual dividend, which was paid on Friday, February 10th. Stockholders of record on Monday, January 23rd were paid a $0.03 dividend. The ex-dividend date was Friday, January 20th. Cooper Companies’s dividend payout ratio (DPR) is currently 0.79%.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Robert W. Baird raised their price objective on Cooper Companies from $371.00 to $385.00 in a research report on Friday, March 3rd. Mizuho raised their price objective on Cooper Companies from $385.00 to $390.00 in a research report on Friday, March 3rd. Piper Sandler raised their price objective on Cooper Companies from $350.00 to $375.00 and gave the company an “overweight” rating in a research report on Wednesday, January 11th. Citigroup raised their price objective on Cooper Companies from $348.00 to $368.00 and gave the company a “buy” rating in a research report on Monday, December 12th. Finally, JPMorgan Chase & Co. increased their target price on Cooper Companies from $300.00 to $330.00 in a research note on Monday, November 28th. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $382.60.

Hedge Funds Weigh In On Cooper Companies

A number of institutional investors and hedge funds have recently modified their holdings of COO. Greenwood Capital Associates LLC purchased a new position in shares of Cooper Companies in the 4th quarter worth $25,000. Belpointe Asset Management LLC purchased a new position in Cooper Companies during the fourth quarter valued at $30,000. Denali Advisors LLC purchased a new position in Cooper Companies during the fourth quarter valued at $33,000. CI Investments Inc. lifted its position in Cooper Companies by 60.7% during the third quarter. CI Investments Inc. now owns 135 shares of the medical device company’s stock valued at $36,000 after purchasing an additional 51 shares in the last quarter. Finally, Standard Family Office LLC purchased a new position in Cooper Companies during the third quarter valued at $37,000. 96.78% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Company Profile

(Get Rating)

The Cooper Cos, Inc operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues.